MAX
| Company | Share, % |
|---|---|
 EyePoint Pharmaceuticals, Inc.
|
0.98 |
 Travere Therapeutics, Inc.
|
0.63 |
 I-Mab
|
0.05 |
| Category | Quantity |
|---|---|
| Healthcare | 3 |
